Yasuo Takehara1, Takashi Aoki2, Mitsuji Yamashita2, Michio Fujie3, Katsuaki Muramatsu3, Harumi Sakahara3, Norihiro Sadato4, Hiroyasu Takeda3
1Radiology, Hamamatsu University
Hospital, Hamamatsu, Shizuoka, Japan; 2Shizuoka University Graduate
School of Technology; 3Hamamatsu University School of Medicine; 4National
Institute for Physiological Science
Newly developed blood pool agent can provide improved and sustained contrast enhancement of experimentally induced rat hypervascular hepatocellular carcinoma with lower dosage of 1/8 of Gd-DTPA at molecular basis.